Cardiff Oncology, Inc.·4

Jun 20, 5:03 PM ET

Mohindru Mani 4

4 · Cardiff Oncology, Inc. · Filed Jun 20, 2023

Insider Transaction Report

Form 4
Period: 2023-06-15
Mohindru Mani
DirectorInterim CEO
Transactions
  • Award

    Stock Options

    2023-06-15+27,70098,501 total
    Exercise: $1.59From: 2024-06-15Exp: 2033-06-15Common Stock (27,700 underlying)

Documents

1 file
  • 4
    wk-form4_1687294992.xmlPrimary

    FORM 4